Dental pulp mesenchymal stem cell therapy (CAR-T (Shanghai) Biotechnology)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameDental pulp mesenchymal stem cell therapy (CAR-T (Shanghai) Biotechnology)
Drug Alias Name牙髓间充质干细胞疗法
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Diabetes Mellitus, Type 1Osteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesCar-T (Shanghai) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCar-T (Shanghai) Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Diabetes Mellitus, Type 1Osteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A